5 / 99
Page 31
Notes:
conferenceseries
.com
Volume 6, Issue 4 (Suppl)
J Nurs Care, an open access journal
ISSN: 2167-1168
Euro Nursing 2017
October 26-28, 2017
32
nd
EURO
NURSING AND MEDICARE SUMMIT
October 26-28, 2017 | Paris, France
Nursing management in malignant hyperthermia
Zuleyha Seki, Nezihe Ugurlu
and
Banu Bayar
Mugla Sitki Kocman University, Turkey
T
he aim of this study is to describe the evidence based protocols in malignant hyperthermia crisis to improve surgical
nurse’s knowledge. To delegate the duties in operating rooms to protect malignant hyperthermia crisis, a literature review
is planned. By reviewing 25 articles, current practices in surgical units are scheduled and regular stimaltion traning programes
are aimed to be given to surgical nurses. While malignant hyperthermia, is a fatal complication which can put the patient’s life
to danger, it is accepted as medical emergency that can ocur in operating rooms during anesthesia applications. With proper
interventions, the mortality rate can be taken down to 5% from 80%. AORN (Association of periOperative Registered Nurse)
malignant hyperthermia guide defines the responsibilities of nurses during the crisis. Malignant hyperthermia crisis can occur
36 hours after anesthesia applications. Nurses must know the signs and cure of the crisis. Dantrolin is used in the crisis period
and it regulates the hyper metabolic findings and muscle constructions. Dantrolin sodium must be prepared with sterile water,
mixed strongly and applied quickly intravenously. Because of this, nurses must be aware of the new knowledge about malignant
hyperthermia crisis and discuss them with their team members regularly.
zuleyhaseki35@gmail.comZuleyha Seki et al., J Nurs Care 2017, 6:4(Suppl)
DOI: 10.4172/2167-1168-C1-061